VIDEO
Sri Lanka’s homegrown cancer product gains global traction
06 Oct 2025
8
A locally developed nutraceutical targeting cancer stem cells is expected to generate around two million U.S. dollars in export revenue for Sri Lanka by 2027, according to Prof. Sameera R. Samarakoon of the Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo.